Stay updated with breaking news from Nasdaq Dice. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SVB Securities downgraded shares of DICE Therapeutics (NASDAQ:DICE – Get Rating) from an outperform rating to a market perform rating in a report released on Wednesday, The Fly reports. DICE has been the topic of several other research reports. TD Cowen started coverage on shares of DICE Therapeutics in a research note on Wednesday, March […]
Guggenheim cut shares of DICE Therapeutics (NASDAQ:DICE – Get Rating) from a buy rating to a neutral rating in a research report report published on Wednesday, The Fly reports. Other equities research analysts also recently issued reports about the stock. TD Cowen assumed coverage on shares of DICE Therapeutics in a research note on Wednesday, […]
HC Wainwright cut shares of DICE Therapeutics (NASDAQ:DICE – Get Rating) from a buy rating to a neutral rating in a research note issued to investors on Wednesday, The Fly reports. HC Wainwright also issued estimates for DICE Therapeutics’ FY2027 earnings at ($5.82) EPS. A number of other equities research analysts have also recently weighed […]
DICE Therapeutics (NASDAQ:DICE – Get Rating) had its price target upped by Wells Fargo & Company from $38.00 to $48.00 in a report released on Tuesday, The Fly reports. Several other brokerages also recently weighed in on DICE. HC Wainwright reiterated a buy rating and set a $60.00 target price on shares of DICE Therapeutics […]
SVB Securities cut shares of DICE Therapeutics (NASDAQ:DICE – Get Rating) from an outperform rating to a market perform rating in a report released on Wednesday morning, The Fly reports. Several other research firms have also commented on DICE. Guggenheim lowered shares of DICE Therapeutics from a buy rating to a neutral rating in a […]